Description
Written primarily for prescribing psychiatrists, 20 chapters that review the state of the field with regard to the use of modern psychiatric drugs in patients aged 18 and under are presented by Rosenberg (Children's Hospital of Michigan), Davanzo (U. of California at Los Angeles), and Gershon (Western Psychiatric Institute and Clinic, U. of Pittsburgh School of Medicine). The first six contributions explore broad issues of pediatric psychopharmacology including historical perspectives, ethical issues, pharmacoepidemiology, research issues, and cardiac side effects. The remaining chapters review clinical information on the general classes of drugs and address the pharmacological treatment of substance abuse disorders and other issues. Annotation c. Book News, Inc., Portland, OR (booknews.com)
Read More
The Second Edition of Pharmacotherapy for Child and Adolescent Psychiatric Disorders contains new and expanded chapters oncombination therapy pharmacoepidemiology pharmacoeconomics current social, ethical, and legal issues surrounding the administration of psychostimulants and antidepressants to children and teenagers serotonin reuptake inhibitors and discusses techniques to select the most appropriate drug and dosing schedule methods to adjust safely and tailor medical treatments for children during various stages of growth and development the effect of psychoactive drugs on cardiac function Offering nearly 3000 contemporary references to facilitate further research, Pharmacotherapy for Child and Adolescent Psychiatric Disorders, Second Edition is a timely and authoritative guide suitable for psychiatrists, psychologists, pediatricians, pharmaceutical and behavioral scientists, clinical neurologists, primary care physicians, social workers, and graduate and medical school students in these disciplines.
Read Less